Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses
Autor: | Ferreri AJ, Reni M, Martelli M, Pangalis G, Frezzato M, Cabras G, Fabbri A, Corazzelli G, Zucca E, Cavalli F |
---|---|
Přispěvatelé: | Ferreri, Aj, Reni, M, Martelli, M, Pangalis, G, Frezzato, M, Cabras, G, Fabbri, A, Corazzelli, G, Zucca, E, Cavalli, F |
Jazyk: | angličtina |
Rok vydání: | 2009 |
Databáze: | OpenAIRE |
Externí odkaz: |